US2020179517A1PendingUtilityA1

Injectable preparation

Assignee: OTSUKA PHARMA CO LTDPriority: Apr 23, 2012Filed: Feb 7, 2020Published: Jun 11, 2020
Est. expiryApr 23, 2032(~5.7 yrs left)· nominal 20-yr term from priority
A61K 9/0019A61K 47/32A61K 47/10A61K 31/496A61K 9/10A61K 9/06A61K 47/38A61P 25/00A61K 9/0024A61P 25/24A61P 25/18
70
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An object of the present invention is to provide a storage-stable injectable preparation comprising a composition comprising a poorly soluble drug as an active ingredient and a dispersion medium. Another object of the present invention is to provide a compact, lightweight prefilled syringe by filling a syringe with the injectable preparation. The present invention provides an injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a specific suspending agent, the composition having a viscosity of 40 pascal-seconds or more in at least one point in the shear rate range of 0.01 to 0.02 s −1 and having a viscosity of 0.2 pascal-seconds or less in at least one point in the shear rate range of 900 to 1,000 s −1 , as measured.

Claims

exact text as granted — not AI-modified
1 . An injectable preparation comprising a composition comprising a poorly soluble drug, a dispersion medium, and a suspending agent, the suspending agent being at least one member selected from the group consisting of (i) and (ii):
 (i) polyvinylpyrrolidone, and   (ii) polyethylene glycol and carboxymethyl cellulose or a salt thereof,   
       the composition having a viscosity of 40 Pa·s or more in at least one point in the shear rate range of 0.01 to 0.02 s −1  and having a viscosity of 0.2 Pa·s or less in at least one point in the shear rate range of 900 to 1,000 s −1 , as measured by a rheometer.

Join the waitlist — get patent alerts

Track US2020179517A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.